CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 126 filers reported holding CASTLE BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,343 | +24.4% | 493,982 | +1.1% | 0.08% | +31.2% |
| Q2 2023 | $6,706 | -40.3% | 488,745 | -1.2% | 0.06% | -41.3% |
| Q1 2023 | $11,241 | -0.4% | 494,781 | +3.2% | 0.11% | -4.4% |
| Q4 2022 | $11,291 | -99.9% | 479,659 | -4.8% | 0.11% | -21.4% |
| Q3 2022 | $13,146,000 | +16.0% | 504,063 | -2.4% | 0.14% | +18.9% |
| Q2 2022 | $11,333,000 | -58.6% | 516,297 | -15.5% | 0.12% | -50.0% |
| Q1 2022 | $27,401,000 | +4.7% | 610,822 | +0.1% | 0.24% | +11.4% |
| Q4 2021 | $26,163,000 | -6.4% | 610,292 | +45.2% | 0.22% | -12.4% |
| Q3 2021 | $27,955,000 | -9.8% | 420,374 | -0.6% | 0.25% | -7.4% |
| Q2 2021 | $31,002,000 | +7.3% | 422,767 | +0.2% | 0.27% | +1.5% |
| Q1 2021 | $28,892,000 | -4.9% | 422,027 | -6.7% | 0.27% | -16.6% |
| Q4 2020 | $30,378,000 | +491.5% | 452,391 | +353.2% | 0.32% | +376.1% |
| Q3 2020 | $5,136,000 | +57.0% | 99,823 | +15.0% | 0.07% | +45.7% |
| Q2 2020 | $3,272,000 | – | 86,803 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |